(Q36426993)

14 August 2017

Primary chemoprevention of familial adenomatous polyposis with sulindac (English)

1 reference

familial adenomatous polyposis

14 August 2017

1 reference

7

Steven Piantadosi

1 reference

14 August 2017

5

Gloria M Petersen

1 reference

14 August 2017

Francis M Giardiello

1

1 reference

14 August 2017

Vincent W Yang

2

1 reference

14 August 2017

Linda M Hylind

3

1 reference

14 August 2017

Anne J Krush

4

1 reference

14 August 2017

Jill D Trimbath

6

1 reference

14 August 2017

Elizabeth Garrett

8

1 reference

14 August 2017

Deborah E Geiman

9

1 reference

14 August 2017

Walter Hubbard

10

1 reference

14 August 2017

G Johan A Offerhaus

11

1 reference

14 August 2017

Stanley R Hamilton

12

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

The New England Journal of Medicine

14 August 2017

1 reference

14 August 2017

346

1 reference

14 August 2017

1054-1059

1 reference

14 August 2017

14

1 reference

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2225537

Tissue prostanoids as biomarkers for chemoprevention of colorectal neoplasia: correlation between prostanoid synthesis and clinical response in familial adenomatous polyposis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2225537

Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2225537

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2225537

Identification of deletion mutations and three new genes at the familial polyposis locus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2225537

Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2225537

Identification of FAP locus genes from chromosome 5q21

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2225537

Identification and characterization of the familial adenomatous polyposis coli gene

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2225537

Sulindac causes regression of rectal polyps in familial adenomatous polyposis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2225537

Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2225537

Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2225537

Rectal cancer in FAP patient after sulindac.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2225537

Sulindac for polyposis of the colon.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2225537

Long-term treatment with sulindac in familial adenomatous polyposis: is there an actual efficacy in prevention of rectal cancer?

21 September 2018

1 reference

12 December 2020

Combinatorial chemoprevention of intestinal neoplasia

1 reference

12 December 2020

Sulindac for polyposis of the colon

1 reference

12 December 2020

Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy

1 reference

12 December 2020

The use and interpretation of commercial APC gene testing for familial adenomatous polyposis

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMOA012015

1 reference

14 August 2017

1 reference

14 August 2017

1 reference